Lignospan Forte Injection, Solution
NDC Package 0362-1096-70

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lignospan Forte (lidocaine hydrochloride and epinephrine) injection is lIGNOSPAN Solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques.Only accepted procedures for these techniques as described in standard textbooks are recommended. This formulation utilizes a injection, solution delivery system. Marketed by Septodont, Inc., this product is identified by NDC 0362-1096 and is authorized under FDA application ANDA088389.

Identification & Billing

NDC Package Code
0362-1096-70
Package Description
5 BLISTER PACK in 1 CARTON / 10 CARTRIDGE in 1 BLISTER PACK / 1.7 mL in 1 CARTRIDGE
Product Code
11-Digit Billing Format
00362109670
RxNorm Crosswalk
  • RxCUI: 1011814 - Lignospan forte 2 % / 1:50,000 in 1.7 mL Dental Cartridge
  • RxCUI: 1011814 - 1.7 ML epinephrine 0.02 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Lignospan]
  • RxCUI: 1011814 - Lignospan forte 2 % / 1:50,000 1.7 ML Dental Cartridge
  • RxCUI: 1657026 - lidocaine HCl 2 % with EPINEPHrine 1:50,000 in 1.7 ML Dental Cartridge
  • RxCUI: 1657026 - 1.7 ML epinephrine 0.02 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge

Clinical Specifications

Proprietary Name
Lignospan Forte
Non-Proprietary Name
Lidocaine Hydrochloride And Epinephrine
Substance Name
Epinephrine Bitartrate; Lidocaine Hydrochloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Submucosal - Administration beneath the mucous membrane.
Usage Information
LIGNOSPAN Solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques.Only accepted procedures for these techniques as described in standard textbooks are recommended.

Regulatory & Marketing

Labeler Name
Septodont, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA088389
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0362-1096-70 identifies a specific commercial package of 5 blister pack in 1 carton / 10 cartridge in 1 blister pack / 1.7 ml in 1 cartridge of Lignospan Forte, a human prescription drug labeled by Septodont, Inc.. This injection, solution is formulated for submucosal use and contains epinephrine bitartrate; lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Septodont, Inc. on December 01, 2017. The current certification is valid through December 31, 2026.

How is this Septodont, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00362109670. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0362-1096-70
11-Digit CMS (5-4-2)
00362-1096-70

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.